Efficacy and safety of the CDK4/6 inhibitor palbociclib during different lines of treatment in patients with advanced stage endocrine sensitive/HER2 negative breast cancer.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_899C43F0DBF7
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
Efficacy and safety of the CDK4/6 inhibitor palbociclib during different lines of treatment in patients with advanced stage endocrine sensitive/HER2 negative breast cancer.
Journal
Journal of Clinical Oncology
Author(s)
Zurcher Jean-Philippe, Aedo Veronica, Stravodimou Athina, Sarivalasis Apostolos, Zaman Khalil
ISSN
0732-183X
1527-7755
Publication state
Published
Issued date
20/05/2018
Volume
36
Number
15_suppl
Pages
e13052-e13052
Language
english
Keywords
Cancer Research, Oncology
OAI-PMH
oai:serval.unil.ch:BIB_899C43F0DBF7
DOI
10.1200/jco.2018.36.15_suppl.e13052
Web of science
000442916004314
Create date
24/08/2021 11:50
Last modification date
19/09/2021 15:55
Usage data